BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 24460325)

  • 1. Selective miRNA expression profile in chronic myeloid leukemia K562 cell-derived exosomes.
    Feng DQ; Huang B; Li J; Liu J; Chen XM; Xu YM; Chen X; Zhang HB; Hu LH; Wang XZ
    Asian Pac J Cancer Prev; 2013; 14(12):7501-8. PubMed ID: 24460325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Revealing genome-wide mRNA and microRNA expression patterns in leukemic cells highlighted "hsa-miR-2278" as a tumor suppressor for regain of chemotherapeutic imatinib response due to targeting STAT5A.
    Kaymaz BT; Günel NS; Ceyhan M; Çetintaş VB; Özel B; Yandım MK; Kıpçak S; Aktan Ç; Gökbulut AA; Baran Y; Can BK
    Tumour Biol; 2015 Sep; 36(10):7915-27. PubMed ID: 25953263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-101 sensitizes K562 cell line to imatinib through Jak2 downregulation and inhibition of NF-κB target genes.
    Farhadi E; Zaker F; Safa M; Rezvani MR
    Tumour Biol; 2016 Oct; 37(10):14117-14128. PubMed ID: 27517565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-146b-5p within BCR-ABL1-Positive Microvesicles Promotes Leukemic Transformation of Hematopoietic Cells.
    Zhang HM; Li Q; Zhu X; Liu W; Hu H; Liu T; Cheng F; You Y; Zhong Z; Zou P; Li Q; Chen Z; Guo AY
    Cancer Res; 2016 May; 76(10):2901-11. PubMed ID: 27013199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD97 promotes gastric cancer cell proliferation and invasion through exosome-mediated MAPK signaling pathway.
    Li C; Liu DR; Li GG; Wang HH; Li XW; Zhang W; Wu YL; Chen L
    World J Gastroenterol; 2015 May; 21(20):6215-28. PubMed ID: 26034356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BCR/ABL mRNA targeting small interfering RNA effects on proliferation and apoptosis in chronic myeloid leukemia.
    Zhu XS; Lin ZY; Du J; Cao GX; Liu G
    Asian Pac J Cancer Prev; 2014; 15(12):4773-80. PubMed ID: 24998540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic myeloid leukemia-derived exosomes promote tumor growth through an autocrine mechanism.
    Raimondo S; Saieva L; Corrado C; Fontana S; Flugy A; Rizzo A; De Leo G; Alessandro R
    Cell Commun Signal; 2015 Feb; 13():8. PubMed ID: 25644060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential role of Notch signalling in CD34+ chronic myeloid leukaemia cells: cross-talk between Notch and BCR-ABL.
    Aljedai A; Buckle AM; Hiwarkar P; Syed F
    PLoS One; 2015; 10(4):e0123016. PubMed ID: 25849484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miRNA-301a induces apoptosis of chronic myelogenous leukemia cells by directly targeting TIMP2/ERK1/2 and AKT pathways.
    Huang X; Qi L; Lu W; Yang G; Chen Y; Zhang R; Rao J; Ji D; Huang R; Chen G
    Oncol Rep; 2017 Feb; 37(2):945-952. PubMed ID: 28035415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Silencing of suppressor of cytokine signaling-3 due to methylation results in phosphorylation of STAT3 in imatinib resistant BCR-ABL positive chronic myeloid leukemia cells.
    Al-Jamal HA; Jusoh SA; Yong AC; Asan JM; Hassan R; Johan MF
    Asian Pac J Cancer Prev; 2014; 15(11):4555-61. PubMed ID: 24969884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. K562 cell-derived exosomes suppress the adhesive function of bone marrow mesenchymal stem cells via delivery of miR-711.
    Jiang YH; Liu J; Lin J; Li SQ; Xu YM; Min QH; Zhong QH; Sun F; Li J; You XH; Liao KL; Qin TY; Zhao C; Huang B; Wang XZ
    Biochem Biophys Res Commun; 2020 Jan; 521(3):584-589. PubMed ID: 31677790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gfi-1 inhibits proliferation and colony formation of p210BCR/ABL-expressing cells via transcriptional repression of STAT 5 and Mcl-1.
    Soliera AR; Mariani SA; Audia A; Lidonnici MR; Addya S; Ferrari-Amorotti G; Cattelani S; Manzotti G; Fragliasso V; Peterson L; Perini G; Holyoake TL; Calabretta B
    Leukemia; 2012 Jul; 26(7):1555-63. PubMed ID: 22285998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Restoration of miR-424 suppresses BCR-ABL activity and sensitizes CML cells to imatinib treatment.
    Hershkovitz-Rokah O; Modai S; Pasmanik-Chor M; Toren A; Shomron N; Raanani P; Shpilberg O; Granot G
    Cancer Lett; 2015 May; 360(2):245-56. PubMed ID: 25697481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exosomes from bulk and stem cells from human prostate cancer have a differential microRNA content that contributes cooperatively over local and pre-metastatic niche.
    Sánchez CA; Andahur EI; Valenzuela R; Castellón EA; Fullá JA; Ramos CG; Triviño JC
    Oncotarget; 2016 Jan; 7(4):3993-4008. PubMed ID: 26675257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Overexpression of Shp-2 is associated with the unlimited growth and apoptosis resistance of p210 bcr-abl-mediated chronic myeloid leukemia].
    Zhu XZ; Yu YZ; Fang YM; Liang Y; Lü QH; Xu RZ
    Zhonghua Yi Xue Za Zhi; 2005 Jul; 85(27):1903-6. PubMed ID: 16255985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Curcumin inhibits in vitro and in vivo chronic myelogenous leukemia cells growth: a possible role for exosomal disposal of miR-21.
    Taverna S; Giallombardo M; Pucci M; Flugy A; Manno M; Raccosta S; Rolfo C; De Leo G; Alessandro R
    Oncotarget; 2015 Sep; 6(26):21918-33. PubMed ID: 26116834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alteration of cellular and immune-related properties of bone marrow mesenchymal stem cells and macrophages by K562 chronic myeloid leukemia cell derived exosomes.
    Jafarzadeh N; Safari Z; Pornour M; Amirizadeh N; Forouzandeh Moghadam M; Sadeghizadeh M
    J Cell Physiol; 2019 Apr; 234(4):3697-3710. PubMed ID: 30317554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modification of Gene Expression, Proliferation, and Function of OP9 Stroma Cells by Bcr-Abl-Expressing Leukemia Cells.
    Supper E; Tahir S; Imai T; Inoue J; Minato N
    PLoS One; 2015; 10(7):e0134026. PubMed ID: 26218064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Profiling of downregulated blood-circulating miR-150-5p as a novel tumor marker for cholangiocarcinoma.
    Wu X; Xia M; Chen D; Wu F; Lv Z; Zhan Q; Jiao Y; Wang W; Chen G; An F
    Tumour Biol; 2016 Nov; 37(11):15019-15029. PubMed ID: 27658773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-cell analysis of K562 cells: an imatinib-resistant subpopulation is adherent and has upregulated expression of BCR-ABL mRNA and protein.
    Karimiani EG; Marriage F; Merritt AJ; Burthem J; Byers RJ; Day PJ
    Exp Hematol; 2014 Mar; 42(3):183-191.e5. PubMed ID: 24269846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.